Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-09-21

FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for venlafaxine hydrochloride from Teva Pharmaceuticals USA, Inc. The approval pertains to changes to the product's labe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Venlafaxine hydrochloride (Venlafaxine hydrochloride)

Snippet

SUPPL AP for VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE HYDROCHLORIDE)